MedPath

Benefits of Unani Medicine(KAHU) in Insomnia disorder

Phase 2
Conditions
Health Condition 1: F510- Insomnia not due to a substance orknown physiological condition
Registration Number
CTRI/2023/06/053789
Lead Sponsor
ational institute of unani medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) Patients exhibiting insomnia, as assessed by the DSM-V Diagnostic Criteria for Insomnia

2) Patients between 18-60 years of age

3) All genders

4) Insomnia severity index >=8

5) Ability to communicate verbally and respond study instrument

6) Willingness to participate in the study and able to sign informed consent

7) Patients having history of Insomnia > 3months

Exclusion Criteria

1) Previous history of known psychiatric disorders

2) Night shift workers

3) Consumption of caffeine beverages (i.e., tea, coffee, or cola) comprising usually more than 5 cups or glasses per day

4) Participation in another trial for insomnia

5) Persons with a history of epilepsy, seizures, or dementia

6) Any significant, severe or unstable, acute or chronically progressive medical or surgical condition

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
â?¢Reduction in Insomnia Severity Index scoreTimepoint: 4 Weeks
Secondary Outcome Measures
NameTimeMethod
â?¢Improvement in subjective parameters <br/ ><br>â?¢Improvement in SF-36 QOL <br/ ><br>Timepoint: 4 Weeks
© Copyright 2025. All Rights Reserved by MedPath